 |
 |

Protein Misfolding and Neurodegeneration
Claudio Soto, PhD;
Lisbell D. Estrada, BSc
Arch Neurol. 2008;65(2):184-189.
A key molecular pathway implicated in diverse neurodegenerative diseases is the misfolding, aggregation, and accumulation of proteins in the brain. Compelling evidence strongly supports the hypothesis that accumulation of misfolded proteins leads to synaptic dysfunction, neuronal apoptosis, brain damage, and disease. However, the mechanism by which protein misfolding and aggregation trigger neurodegeneration and the identity of the neurotoxic structure is still unclear. The aim of this article is to review the literature around the molecular mechanism and role of misfolded protein aggregates in neurodegeneration and the potential for the misfolding process to lead to a transmissible form of disease by a prion-based model of propagation.
Author Affiliations: Departments of Neurology, Neuroscience and Cell Biology, and Biochemistry and Molecular Biology, George and Cynthia Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston (Dr Soto and Ms Estrada); and Facultad de Ciencias, Universidad de Chile, Santiago, Chile (Ms Estrada).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Neuronal circuitry regulates the response of Caenorhabditis elegans to misfolded proteins
Prahlad and Morimoto
Proc. Natl. Acad. Sci. USA 2011;108:14204-14209.
ABSTRACT
| FULL TEXT
Early Failure of N-Methyl-D-aspartate Receptors and Deficient Spine Formation Induced by Reduction of Regulatory Heme in Neurons
Chernova et al.
Mol. Pharmacol. 2011;79:844-854.
ABSTRACT
| FULL TEXT
Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS
Vassall et al.
Proc. Natl. Acad. Sci. USA 2011;108:2210-2215.
ABSTRACT
| FULL TEXT
Alzheimer's disease peptide {beta}-amyloid interacts with fibrinogen and induces its oligomerization
Ahn et al.
Proc. Natl. Acad. Sci. USA 2010;107:21812-21817.
ABSTRACT
| FULL TEXT
Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid {beta}-Protein (A{beta}) Assembly from Alzheimer Disease Brains
Noguchi et al.
J. Biol. Chem. 2009;284:32895-32905.
ABSTRACT
| FULL TEXT
Design of anti- and pro-aggregation variants to assess the effects of methionine oxidation in human prion protein
Wolschner et al.
Proc. Natl. Acad. Sci. USA 2009;106:7756-7761.
ABSTRACT
| FULL TEXT
Functional Protein Delivery into Neurons Using Polymeric Nanoparticles
Hasadsri et al.
J. Biol. Chem. 2009;284:6972-6981.
ABSTRACT
| FULL TEXT
Central Role of {alpha}-Synuclein Oligomers in Neurodegeneration in Parkinson Disease
Kazantsev and Kolchinsky
Arch Neurol 2008;65:1577-1581.
ABSTRACT
| FULL TEXT
|